The ARTH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARTH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARTH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ARTH Detailed Price Forecast - CNN Money | View ARTH Detailed Summary - Google Finance | ||
View ARTH Detailed Summary - Yahoo! Finance | View ARTH Stock Research & Analysis - Zacks.com |
View ARTH Trends & Analysis - Trade-Ideas | View ARTH Major Holders - Barrons | ||
View ARTH Call Transcripts - NASDAQ | View ARTH Breaking News & Analysis - Seeking Alpha | ||
View ARTH Annual Report - CompanySpotlight.com | View ARTH OTC Short Report - OTCShortReport.com | ||
View ARTH Fundamentals - TradeKing | View ARTH SEC Filings - Bar Chart | ||
View Historical Prices for ARTH - The WSJ | View Performance/Total Return for ARTH - Morningstar | ||
View the Analyst Estimates for ARTH - MarketWatch | View the Earnings History for ARTH - CNBC | ||
View the ARTH Earnings - StockMarketWatch | View ARTH Buy or Sell Recommendations - MacroAxis | ||
View the ARTH Bullish Patterns - American Bulls | View ARTH Short Pain Metrics - ShortPainBot.com |
View ARTH Stock Mentions - StockTwits | View ARTH Stock Mentions - PennyStockTweets | ||
View ARTH Stock Mentions - Twitter | View ARTH Investment Forum News - Investor Hub | ||
View ARTH Stock Mentions - Yahoo! Message Board | View ARTH Stock Mentions - Seeking Alpha |
View Insider Transactions for ARTH - SECform4.com | View Insider Transactions for ARTH - Insider Cow | ||
View ARTH Major Holdings Summary - CNBC | View Insider Disclosure for ARTH - OTC Markets | ||
View Insider Transactions for ARTH - Yahoo! Finance | View Institutional Holdings for ARTH - NASDAQ |
View ARTH Stock Insight & Charts - FinViz.com | View ARTH Investment Charts - StockCharts.com | ||
View ARTH Stock Overview & Charts - BarChart | View ARTH User Generated Charts - Trading View |
Arch Therapeutics Provides Year End Operational Update
Posted on Thursday November 09, 2023
Continued Strong Trends in Orders and Paid ClaimsFRAMINGHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today provided a year-end operational update, including key performance metrics related to the ongoing commercialization activities for the Company’s first product, AC5® Advanced Wound System (“AC5”). During its fourth fiscal quarter, the Company
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
Posted on Thursday November 02, 2023
AC5® Advanced Wound System to be Featured in the Hands-On Skills Lab for Clinicians and a Clinical Case Poster Demonstrating Utility in Treatment of Venous Leg UlcersFRAMINGHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today announced that the Company’s first commercial product, AC5® Advanced Wound System (“AC5”), will be featured at the 2023 Symposium on Advanc
Arch Therapeutics Provides AC5® Commercialization Update
Posted on Wednesday September 13, 2023
Orders and Paid Claims Increasing Since Rollout of Reimbursement CodeFRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today provided a commercialization update on the Company’s first product, AC5® Advanced Wound System. Since the Centers for Medicare and Medicaid Services (“CMS”) established A2020, a Level II Healthcare Common Procedure Codi
Arch Therapeutics Completes Financing as Bridge to Uplisting
Posted on Thursday September 07, 2023
Common Stock Listing on National Exchange is Next Planned Significant MilestoneFRAMINGHAM, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that it completed a private placement with institutional and accredited individual investors (collectively, the “Investors”) as a Bridge Offering preceding a planned national exchange listing of the